Remove Medicare Remove Pharmaceutical Remove Promotion
article thumbnail

Collaborative Arrangement laws scrapped so more nurses can work to full scope

Nursing Review

The laws have historically prevented nurses from providing Medicare subsidised services and prescribing certain medications available on the Pharmaceutical Benefits Scheme (PBS) without a supervising medical practitioner. It is also contrary to the expert clinical advice of the MBS Review Taskforce.”

article thumbnail

One nurse’s perspective: How to resolve the high cost of healthcare in the United States

American Nurse

healthcare costs continue to rise, patients are accountable for paying the balance of their medical bills to insurance companies, hospitals, and pharmaceutical companies (the medical–industrial complex). A universal healthcare plan similar to Medicare could provide basic, free healthcare to all U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Lived Experience of Providing Preventative Caries Care in Missouri Post COVID-19 and Cannabis Legalization

American Nurse

Missouri skilled nursing facility residents (N=253) reported that 49% of residents rely on staff to clean their mouth, many have no Medicare dental coverage, and Medicaid covers a limited number of dental services (The Oral Health of Adults, 2022). Participant #1 states promoting prophylaxis and twice-yearly preventative treatment.

article thumbnail

Cancer Drug Shortage After Drugmakers Abandon Cheap Generics

Scrubs

22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags full of shredded documents tossed into a garbage truck. And pharmaceutical industry product recalls are at their highest level in 18 years, reflecting fragile supply conditions.

article thumbnail

Inflation Reduction Act Imposes Prescription Drug Pricing Reforms

Healthcare Law Insights blog

The Act includes provisions targeting Medicare prescription drug costs, which could have wide-ranging effects for any party involved in the pharmaceutical industry, including drug developers, researchers, manufacturers, distributors, insurance companies, pharmacy associations and consumers. What this means to you.